Home/News/CellulaREvolution raises £1.75m to accelerate the launch of their Continuous Cell Culture Technology.
CellulaREvolution raises £1.75m to accelerate the launch of their Continuous Cell Culture Technology.
Biotech technology disrupter CellulaREvolution, which aims to revolutionise the way cells are
grown, has raised £1.75 million from a group of notable investors in a round led by
Happiness Capital also includes Allusion One, the first investment arm of Allusion. The
investment will be used to accelerate research & development and strengthen their
commercial team as they prepare to take their bioreactor technologies to market.
Eric Ng, CEO at Happiness Capital, said: “We have taken an in-depth look at the industry
and considered that CellulaREvolution has a unique b2b offering which is expected to have
a huge impact on the cost-efficient commercialization of cultured meat in the coming years.
We are keen to support the Company on their journey and look forward to being an active
Cultivated meat producers continue to face countless challenges as they strive to achieve
price-parity with conventionally grown meat. The upstream technologies developed by
CellulaREvolution will be of critical importance in establishing cultivated meat as a realistic,
viable and attractive alternative to factory farming in meeting the world’s growing demand for
food. The technology also has applications in the biologics and cell therapeutics verticals,
further strengthening the company’s future competitive position.
Leo Groenewegen CEO of CellulaREvolution said “I am delighted to announce the
investment from Happiness Capital and Allusion One. We have been able to secure growth
funding from very reputable investors and are now ready to accelerate the development of
our products and our company at an increased pace. Looking forward we will be bringing our
enabling technologies to market soon, doing our part to bring high quality and affordably
cultured meat to consumer’s plate sooner rather than later!”
This funding follows a seed investment of £1.2m in January 2021, when most notably, CPT
Capital, an expert investor in the alternative protein space and early investors in the world’s
leading cultivated meat producers, participated in the round joining existing investors
Northstar Ventures and the Northern Accelerator Seed Investment Fund (NASIF). NASIF
invests on behalf of the North East’s universities
The investment closely follows the appointment of Chris Green as Chief Commercial Officer.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.